3.48 The Predictive Value of High Tumor Mutational Burden with Dr. Luc Morris
Plenary Session - En podcast af Vinay Prasad, MD MPH
Kategorier:
Today we interview Dr. Luc Morris of Memorial Sloan Kettering Cancer Center on his new paper out now in JAMA Oncology titled "Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase". Response Rates: doi.org/10.1001/jamaoncol.2020.7684 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
